|
Volumn 46, Issue 8, 2002, Pages 2700-2703
|
Biguanide-atovaquone synergy against Plasmodium falciparum in vitro
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 DIAMINO 6 (2 NAPHTHYLSULFONYL)QUINAZOLINE;
4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE;
ATOVAQUONE;
ATOVAQUONE PLUS PROGUANIL;
BIGUANIDE;
CHLORCYCLOGUANIL;
CHLORPROGUANIL;
CYCLOGUANIL;
DOXYCYCLINE;
N [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] N' ISOPROPYLIMIDOCARBONIMIDIC DIAMIDE;
PHENFORMIN;
PROGUANIL;
PYRIMETHAMINE;
TETRACYCLINE DERIVATIVE;
TRIAZINE DERIVATIVE;
UNCLASSIFIED DRUG;
WR 159412;
ANTIINFECTIVE AGENT;
ANTIMALARIAL AGENT;
BIGUANIDE DERIVATIVE;
NAPHTHOQUINONE;
ANTIMALARIAL ACTIVITY;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFICACY;
DRUG POTENTIATION;
MALARIA;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
TREATMENT PLANNING;
ANIMAL;
DRUG COMBINATION;
DRUG EFFECT;
DRUG INTERACTION;
ANIMAL;
ANTIBIOTICS, TETRACYCLINE;
ANTIMALARIALS;
BIGUANIDES;
DRUG COMBINATIONS;
DRUG INTERACTIONS;
NAPHTHOQUINONES;
PLASMODIUM FALCIPARUM;
PYRIMETHAMINE;
TRIAZINES;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ATOVAQUONE;
TETRACYCLINES;
|
EID: 0035992005
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.8.2700-2703.2002 Document Type: Article |
Times cited : (20)
|
References (24)
|